Výsledky vyhledávání

Akademický článek

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

Autor: Samuel Rosner, Erica Kwong, Alexander N. Shoushtari, Claire F. Friedman, Allison S. Betof, Mary Sue Brady, Daniel G. Coit, Margaret K. Callahan, Jedd D. Wolchok, Paul B. Chapman, Katherine S. Panageas, Michael A. Postow

Publikováno v: Cancer Medicine, Vol 7, Iss 3, Pp 690-697 (2018)

Abstract Both the combination of nivolumab + ipilimumab and single‐agent anti‐PD‐1 immunotherapy have demonstrated survival benefit for patients with advanced melanoma. As the combination has a high rate of serious side effects, further analyse

Externí odkaz: https://doaj.org/article/40cdf6b335224da48d2ae318d785a6cf

Zobrazit plný text záznamu

Plný text ve formátu HTML

Changes in the Activity Measure for Post-Acute Care Domains in Persons With Stroke During the First Year After Discharge From Inpatient Rehabilitation

Autor: Michael W. O'Dell, Erica Kwong, Megan Frantz, Michael Taub, Ruchi Patel, Karen Wen, Marc Campo, Abhishek Jaywant, Joan Toglia

Publikováno v: Archives of physical medicine and rehabilitation. 102(4)

Objective To describe functional changes after inpatient stroke rehabilitation using the Activity Measure for Post-Acute Care (AM-PAC), an assessment measure sensitive to change and with a low risk of ceiling effect. Design Retrospective, longitudina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2a2838fb5e62922638c1edc76ab4865
https://pubmed.ncbi.nlm.nih.gov/33440132

Zobrazit plný text záznamu

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

Autor: Jedd D. Wolchok, Daniel G. Coit, Claire F. Friedman, Alexander N. Shoushtari, Erica Kwong, Margaret K. Callahan, Mary Sue Brady, Katherine S. Panageas, Michael A. Postow, Samuel Rosner, Paul B. Chapman, Allison S. Betof

Publikováno v: Cancer Medicine

Both the combination of nivolumab + ipilimumab and single‐agent anti‐PD‐1 immunotherapy have demonstrated survival benefit for patients with advanced melanoma. As the combination has a high rate of serious side effects, further analyses in rand

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b21219cb726eaf1d883f9b9c42b61d
https://pubmed.ncbi.nlm.nih.gov/29468834

Zobrazit plný text záznamu

Responsiveness of the activity measure for post-acute care (AM-PAC) from discharge from inpatient stroke rehabilitation to six month follow-up

Autor: Joan Toglia, Megan Frantz, R. Patel, Michael W. O'Dell, Abhishek Jaywant, Erica Kwong, Michael Taub

Publikováno v: Annals of Physical and Rehabilitation Medicine. 61:e179

Introduction/Background Functional stroke scales must detect significant change over time, but defining “significant” is difficult. The activity measure for post-acute care (AM-PAC) measures activity limitations in 3 domains: basic mobility (BM),

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3056001915c16d40398820a6253357a5
https://doi.org/10.1016/j.rehab.2018.05.409

Zobrazit plný text záznamu

Clinical and immunologic variables associated with outcomes following combination ipilimumab and nivolumab immunotherapy in melanoma

Autor: Michael A. Postow, Erica Kwong, Katherine S. Panageas, Samuel Rosner

Publikováno v: Journal of Clinical Oncology. 35:55-55

55 Background: Prior studies have shown routine laboratory parameters such as lymphocytes (lymphs) and eosinophils (eos) are associated with outcome in patients (pts) treated with ipilimumab (ipi) or programmed death-1 (PD-1) agents as single drugs.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68d9f366b66a0d47b8ac8772b05ab837
https://doi.org/10.1200/jco.2017.35.7_suppl.55

Zobrazit plný text záznamu